Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty

PHASE2RecruitingINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

March 13, 2024

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions
Knee Replacement SurgeryOsteoarthritis, Knee
Interventions
DRUG

Epidiolex oral solution

"Participants assigned to CBD will take the medication one hour before or two hours after eating a meal.~If participants can't tolerate the full-strength dose, the participant can decrease the dosing to 0.75 milliliter twice a day. If this is still not well tolerated, dosing can further be decreased to 0.75 milliliter once per day in the evening."

OTHER

Placebo

Participants will be instructed to take one hour before or two hours after eating a meal.

Trial Locations (2)

48109

RECRUITING

University of Michigan, Ann Arbor

48202

NOT_YET_RECRUITING

Henry Ford Health System, Detroit

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Chad Brummett

OTHER